KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Long-Term Investments (2016 - 2025)

Cvs Health's Long-Term Investments history spans 10 years, with the latest figure at $34.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 11.08% year-over-year to $34.8 billion, compared with a TTM value of $34.8 billion through Dec 2025, up 11.08%, and an annual FY2025 reading of $34.8 billion, up 11.08% over the prior year.
  • Long-Term Investments for Q4 2025 was $34.8 billion at Cvs Health, up from $33.7 billion in the prior quarter.
  • The five-year high for Long-Term Investments was $34.8 billion in Q4 2025, with the low at $20.6 billion in Q3 2022.
  • Average Long-Term Investments over 5 years is $26.2 billion, with a median of $24.9 billion recorded in 2023.
  • Year-over-year, Long-Term Investments decreased 8.61% in 2022 and then soared 46.51% in 2024.
  • Tracing CVS's Long-Term Investments over 5 years: stood at $26.1 billion in 2021, then dropped by 8.61% to $23.9 billion in 2022, then decreased by 3.65% to $23.0 billion in 2023, then soared by 36.15% to $31.3 billion in 2024, then rose by 11.08% to $34.8 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Long-Term Investments are $34.8 billion (Q4 2025), $33.7 billion (Q3 2025), and $29.9 billion (Q2 2025).